Table 5: Correlation between Dosing and AKI Incidence
Median Total Daily Dose (n=151) Median Total Daily Dose (n=151)
Developed AKI, mg/kg (standard deviation) 13 (3.02)
Did NOT Develop AKI, mg/kg (standard deviation) 12 (2.29)
Dosing Frequency ≥ Every 24 Hours (n=129) Dosing Frequency ≥ Every 24 Hours (n=129)
Developed AKI, n (%) 37 (28.7%)
Did NOT Develop AKI, n (%) 92 (71.3%)
Dosing Frequency < Every 24 Hours (n=22) Dosing Frequency < Every 24 Hours (n=22)
Developed AKI, n (%) 11 (50%)
Did NOT Develop AKI, n (%) 11 (50%)
Pearson Chi-Square 2-sided significance: p=0.047 Pearson Chi-Square 2-sided significance: p=0.047